We are live on
!
Find out more
VEA
Virtus ETF Advisers Portfolio holdings
AUM
$215M
1-Year Est. Return
53.68%
This Fund
S&P 500
This Quarter
Est. Return
-2.98%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$251M
AUM Growth
-$19M
(-7%)
Cap. Flow
-$2.24M
Cap. Flow
% of AUM
-0.89%
Top 10 Holdings %
Top 10 Hldgs %
7.1%
Holding
477
New
43
Increased
256
Reduced
137
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
The Mosaic Company
MOS
|
+$962K |
| 2 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$944K |
| 3 |
Enphase Energy
ENPH
|
+$834K |
| 4 |
Devon Energy
DVN
|
+$751K |
| 5 |
Gartner
IT
|
+$742K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$785K |
| 2 |
L3Harris
LHX
|
+$740K |
| 3 |
Agilent Technologies
A
|
+$713K |
| 4 |
Copart
CPRT
|
+$688K |
| 5 |
Cheniere Energy
CQP
|
+$687K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.83% |
| 2 | Real Estate | 17.55% |
| 3 | Materials | 12.77% |
| 4 | Financials | 9.88% |
| 5 | Energy | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Prospect Capital
PSEC
$1.12B
| $359K | 0.14% |
57,940
-21,720
| -27% | -$162K |
|
252
Golub Capital BDC
GBDC
$3.38B
| $357K | 0.14% |
28,792
-8,539
| -23% | -$116K |
|
253
Hercules Capital
HTGC
$3.04B
| $354K | 0.14% |
30,591
-11,427
| -27% | -$163K |
|
254
Nuveen Floating Rate Income Fund
JFR
$1.24B
| $354K | 0.14% |
43,678
-11,997
| -22% | -$103K |
|
255
Alnylam Pharmaceuticals
ALNY
$38.5B
| $352K | 0.14% |
1,761
+23
| +1% | +$4.39K |
|
256
WhiteHorse Finance
WHF
$139M
| $351K | 0.14% |
31,629
-16,585
| -34% | -$229K |
|
257
Ares Capital
ARCC
$13.7B
| $347K | 0.14% |
20,578
-9,764
| -32% | -$189K |
|
|
BPMC
258
DELISTED
Blueprint Medicines
BPMC
| $340K | 0.14% |
5,165
+76
| +1% | +$4.88K |
|
259
BlackRock Floating Rate Income Trust
BGT
$322M
| $338K | 0.13% |
31,139
-9,087
| -23% | -$104K |
|
260
Saratoga Investment
SAR
$314M
| $337K | 0.13% |
16,210
-1,058
| -6% | -$25.4K |
|
261
Zai Lab
ZLAB
$2.1B
| $336K | 0.13% |
9,812
+143
| +1% | +$6.12K |
|
|
BSL
262
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$168M
| $335K | 0.13% |
26,682
-6,988
| -21% | -$93.2K |
|
|
EFR
263
Eaton Vance Senior Floating-Rate Fund
EFR
$312M
| $335K | 0.13% |
30,148
-6,657
| -18% | -$80.6K |
|
264
Crescent Capital BDC
CCAP
$412M
| $334K | 0.13% |
22,218
-3,834
| -15% | -$64.7K |
|
265
Gladstone Capital
GLAD
$436M
| $328K | 0.13% |
19,312
-1,055
| -5% | -$21.5K |
|
|
EVF
266
Eaton Vance Senior Income Trust
EVF
$89.9M
| $327K | 0.13% |
61,965
-15,131
| -20% | -$84.3K |
|
267
Biogen
BIIB
$30.4B
| $324K | 0.13% |
1,215
+20
| +2% | +$4.25K |
|
|
EFT
268
Eaton Vance Floating-Rate Income Trust
EFT
$284M
| $324K | 0.13% |
28,563
-7,535
| -21% | -$91K |
|
269
BlackRock Floating Rate Income Strategies Fund
FRA
$381M
| $322K | 0.13% |
29,242
-9,805
| -25% | -$117K |
|
270
BioCryst Pharmaceuticals
BCRX
$2.48B
| $314K | 0.13% |
24,920
+364
| +1% | +$4.68K |
|
271
Ionis Pharmaceuticals
IONS
$9.14B
| $311K | 0.12% |
7,029
+104
| +2% | +$4.38K |
|
|
FOLD
272
DELISTED
Amicus Therapeutics
FOLD
| $310K | 0.12% |
29,698
+435
| +1% | +$4.85K |
|
273
Barings BDC
BBDC
$885M
| $308K | 0.12% |
37,228
-4,546
| -11% | -$43.9K |
|
274
Enanta Pharmaceuticals
ENTA
$367M
| $305K | 0.12% |
5,883
+85
| +1% | +$4.97K |
|
275
Oaktree Specialty Lending
OCSL
$1.06B
| $305K | 0.12% |
16,948
-3,865
| -19% | -$78.7K |
|
Similar funds
NCM
SSA
LIWM
VFG
IAM
1M
GC
RC
Virtus ETF Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Virtus ETF Advisers held 477 positions worth $251M, down 7% from $270M the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Virtus ETF Advisers's Q3 2022 filing shows 43 new, 256 increased, 137 reduced and 41 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K. The largest sale was Moderna, an estimated $785K.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Real Estate and Materials.
- Virtus ETF Advisers's largest Q3 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 11,040 shares worth $877K.
- Virtus ETF Advisers added most to The Mosaic Company in Q3 2022, an estimated $962K increase.
- Virtus ETF Advisers's biggest Q3 2022 reduction was Moderna, cutting an estimated $785K.
- Virtus ETF Advisers fully exited L3Harris in Q3 2022, selling an estimated $740K.
- Virtus ETF Advisers's ten largest holdings make up 7.1% of its $251M portfolio in Q3 2022.
- Virtus ETF Advisers opened 43 new positions and closed 41 in Q3 2022.
- Virtus ETF Advisers's portfolio value fell 7% quarter-over-quarter to $251M.
Based on Virtus ETF Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.